|
|
Title | Creator | Relation Is Part Of |
51 |
|
Optic Nerve Hypoplasia in Autosomal Dominant Optic Atrophy | Michelle Ariss; Dan Milea; Marianne Wegener; Michael Larsen; Elias Traboulsi | NANOS 2009: Poster Presentations |
52 |
|
Redox Sensitivity of Retinal Ganglion Cells: A Mechanism for Mitochondrial Optic Neuropathy? | Leonard A. Levin | NANOS 1998: Platform Presentations (Session I) |
53 |
|
Relative Sparing of Afferent Pupillary Pathways in LHON: A Postmortem Study | Swaraj Bose, MD; Varerio Carelli, PhD; Alfredo Sadun, MD, PhD | NANOS 2002: Scientific Platform Presentations Session 2 |
54 |
|
Acquired Mitochondrial Optic Neuropathies | Alfredo A. Sadun; Yoji Kashima; Jung Dao | NANOS 1995: Science Platform Presentations (Session I) |
55 |
|
The Genetic Testing Paradigm for Leber's Hereditary Optic Neuropathy: Discovery of a New Candidate LHON Mitochondrial DNA Mutation | Michael D. Brown, PhD; Valerie Biousse, MD; Seyed Hosseini, PhD; Douglas C. Wallace, PhD; Nancy J. Newman, MD | NANOS 2004: Poster Presentations |
56 |
|
Health-Related Quality of Life for Persons Affected by Leber's Optic Neuropathy | Michael P. O'Conner; Martin W. tenHove | NANOS 2000: Poster Presentations |
57 |
|
Infantile presentation of Leber's hereditary optic neuropathy ‘plus' disease | Helena Zakrzewski; Walla Al-Hertani; Milad Modabber; Daniela Toffoli | NANOS 2017: Poster Presentations |
58 |
|
Leber Hereditary Optic Neuropathy With Neuromyelitis Optica (NMO)-Like Presentation in 14-year-old Male | Angela J. Kim; Ramiro Maldonado; Joshua Chalkley; Padmaja Sudhakar | NANOS Annual Meeting 2022: Poster Session I: Neuro-Ophthalmic Disorders of Neurologic and Systemic Diseases |
59 |
|
Field Investigation In Brazil of a Giant Pedigree of Leber's Hereditary Optic Neuropathy | Alfredo A. Sadun; P. Quiros; V. Carelli; S. Salomao; A. Berezuzsky; R. Belfort; F. Sadun; A.M. DeNegri | NANOS 2002: Scientific Platform Presentations Session 2 |
60 |
|
GSTM1 and GSTT1 Deletion Genotypes in Various Spontaneous Optic Neuropathies | Khaled Abu-Amero; Barry Milcarek; Thomas Bosley | NANOS 2009: Scientific Platform Presentations (Session I) |
61 |
|
Leber Hereditary Optic Neuropathy Gene Therapy Clinical Trial for G11778A Mutation: Serial Pretreatment Evaluation from Baseline to One Year | Byron Lam; John Guy; Fawzi Abukhalil; Vittorio Porciatti; William Feuer; Alexis Morante | NANOS 2011: Poster Presentations |
62 |
|
Preliminary Safety and Tolerability Results Of A Recombinant Adeno-Associated Viral Vector Serotype 2 | Catherine Vignal-Clermont; Geraldine Honnet; Anne Galy; Nitza Thomasson; Marisol Corral-Debrinsky; Scott Uretsky; Jean-Philippe Combal; Serge Fitoussi; Jose-Alain Sahel | NANOS Annual Meeting 2015 Platform Session 1 |
63 |
|
Visual Loss Due to ATP Defieciency: A Genre of Optic Neuropathy | Joseph F. Rizzo III, MD | NANOS 1992: Clinical Presentations (Session 2) |
64 |
|
Retinal vascular geometry and tortuosity changes in patients with Leber hereditary optic neuropathy (LHON) | Neringa Jurkute; Anna Majander; Andrew Webster; Marcela Votruba; Maged Habib; Bashir Al-Diri; Patrick Yu-Wai-Man | NAM 2019: Poster Session II: Scientific Advancements in Neuro-Ophthalmology |
65 |
|
Characterization of Leber's Hereditary Optic Neuropathy Patients Treated with Idebenone | Jasdeep S. Chahal; Michael J. Ammar; Rustum Karanjia; Alfredo Sadun | |
66 |
|
Clinical experience with Idebenone (Raxone) in the treatment of patients with Lebers Hereditary Optic Neuropathy (LHON) | Thomas Meier | NANOS 2014: Scientific Platform Presentations (Session 2) |
67 |
|
Leber Hereditary Optic Neuropathy G11778A Gene Therapy Clinical Trial: Stability of Clinical Parameters in Preparatory Phase Based on Onset of Visual Loss | Byron L. Lam; John R. Guy; William J. Feuer; Vittorio Porciatti; Ruth Vandenbroucke; Joyce C. Schiffman | NANOS 2013: Platform Presentations (Session II) |
68 |
|
Leber Hereditary Optic Neuropathy G11778A Gene Therapy Clinical Trial: Stability of Clinical Parameters in Preparatory Phase Based on Onset of Visual Loss | Byron L. Lam; John R. Guy; William J. Feuer; Vittorio Porciatti; Ruth Vandenbroucke; Joyce C. Schiffman | NANOS 2013: Platform Presentations (Session II) |
69 |
|
Leber Hereditary Optic Neuropathy G11778A Gene Therapy Clinical Trial: Stability of Clinical Parameters of Carriers in Preparatory Phase | Byron L. Lam; William J. Feuer; Vittorio Porciatti; Ruth Vandenbrke; Joyce C. Schiffman; Fawzi Abukhalil; Potyra R. Rosa; Sophia Cuprill-Nilson; John Guy | NANOS 2014: Scientific Platform Presentations (Session 2) |
70 |
|
Leber Hereditary Optic Neuropathy G11778A Gene Therapy Clinical Trial: Stability of Clinical Parameters of Carriers in Preparatory Phase | Byron L. Lam; William J. Feuer; Vittorio Porciatti; Ruth Vandenbroucke; Joyce Schiffman; Fawzi Abukhalil; Potyra R. Rosa; Sophia Cuprill-Nilson; John Guy | NANOS 2014: Scientific Platform Presentations (Session 2) |
71 |
|
Leber's Hereditary Optic Neuropathy in Women | Giulia Amore; Martina Romagnoli; Chiara La Morgia; Michele Carbonelli; Francesca Allegrini; Rustum Karanjia; Alfredo Sadun; Valerio Carelli | NANOS Annual Meeting 2021: Scientific Platform Session II |
72 |
|
Long Term Treatment of Lebers Hereditary Optic Neuropathy With Idebenone | Jennifer I. Doyle; Brendan D. Grondines; Michael S. Vaphiades | |
73 |
|
Mitochondrial Cytopathies | Gregory Kosmorsky DO; D. Johns MD | NANOS 1991: Pediatric Neuro-Ophthalmology Symposium |
74 |
|
Asynchronous Onset in Leber's Hereditary Optic Neuropathy | Rustum Karanjia; Henry Liu; Chiara LaMorgia; Samir Nazarali; Lidia Di Vito; Michele Carbonelli; Alexander Pearson; Neringa Jurkute; Piero Barboni; Anna Maria De Negri; Patrick Yu-Wai Man; Valerio Carelli; Alfredo Sadun | NANOS 2018: Poster Presentations |
75 |
|
Leber's Hereditary Optic Neuropathy in Women | Giulia Amore; Martina Romagnoli; Chiara La Morgia; Michele Carbonelli; Francesca Allegrini; Rustum Karanjia; Alfredo Sadun; Valerio Carelli | NANOS Annual Meeting 2021: Scientific Platform Session II |